1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Akke, M. Forsen, S. Chazin, W.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 252 102 121 10.1006/jmbi.1995.0478 7666423 Solution structure of (Cd2+)1-calbindin D9k reveals details of the stepwise structural changes along the Apo-->(Ca2+)II1-->(Ca2+)I,II2 binding pathway. 1995 UK J.Mol.Biol. JMOBAK 0070 0022-2836 249 441 Determination of the Solution Structure of Apo Calbindin D9K by NMR Spectroscopy 1995 UK J.Mol.Biol. JMOBAK 0070 0022-2836 231 711 High-Resolution Solution Structure of Calcium-Loaded Calbindin D9K 1993 UK J.Mol.Biol. JMOBAK 0070 0022-2836 220 173 Molecular Basis for Co-Operativity in Ca2+ Binding in Calbindin D9K. 1H Nuclear Magnetic Resonance Studies of (Cd2+)1-Bovine Calbindin D9K 1991 10.2210/pdb1cdn/pdb pdb_00001cdn 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 BOVINE MINOR A FORM, CADMIUM-HALF-SATURATED, CADMIUM ION IS BOUND IN C-TERMINAL SITE 8601.688 CALBINDIN D9K INS(MET 1), P43G 1 man polymer INTESTINAL CALCIUM-BINDING PROTEIN, ICBP, ICABP, CABP9K, S100D no no MKSPEELKGIFEKYAAKEGDPNQLSKEELKLLLQTEFPSLLKGGSTLDELFEELDKNGDGEVSFEEFQVLVKKISQ MKSPEELKGIFEKYAAKEGDPNQLSKEELKLLLQTEFPSLLKGGSTLDELFEELDKNGDGEVSFEEFQVLVKKISQ A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n cattle Bos Escherichia sample ICABP 9913 Bos taurus ICABP 562 Escherichia coli PICB1 database_2 pdbx_database_status pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations Other 1 0 1995-11-14 1 1 2008-03-03 1 2 2011-07-13 1 3 2021-11-03 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _pdbx_nmr_software.name _struct_ref_seq_dif.details Y BNL 1995-08-04 REL REL 24 HAVEL,WUTHRICH refinement DISGEO PEARLMAN,CASE,CALDWELL,SEIBEL,SINGH,WEINER,KOLLMAN refinement Amber 4.0 n 1 0 A LYS 1 n 2 LYS 1 A SER 2 n 3 SER 2 A PRO 3 n 4 PRO 3 A GLU 4 n 5 GLU 4 A GLU 5 n 6 GLU 5 A LEU 6 n 7 LEU 6 A LYS 7 n 8 LYS 7 A GLY 8 n 9 GLY 8 A ILE 9 n 10 ILE 9 A PHE 10 n 11 PHE 10 A GLU 11 n 12 GLU 11 A LYS 12 n 13 LYS 12 A TYR 13 n 14 TYR 13 A ALA 14 n 15 ALA 14 A ALA 15 n 16 ALA 15 A LYS 16 n 17 LYS 16 A GLU 17 n 18 GLU 17 A GLY 18 n 19 GLY 18 A ASP 19 n 20 ASP 19 A PRO 20 n 21 PRO 20 A ASN 21 n 22 ASN 21 A GLN 22 n 23 GLN 22 A LEU 23 n 24 LEU 23 A SER 24 n 25 SER 24 A LYS 25 n 26 LYS 25 A GLU 26 n 27 GLU 26 A GLU 27 n 28 GLU 27 A LEU 28 n 29 LEU 28 A LYS 29 n 30 LYS 29 A LEU 30 n 31 LEU 30 A LEU 31 n 32 LEU 31 A LEU 32 n 33 LEU 32 A GLN 33 n 34 GLN 33 A THR 34 n 35 THR 34 A GLU 35 n 36 GLU 35 A PHE 36 n 37 PHE 36 A PRO 37 n 38 PRO 37 A SER 38 n 39 SER 38 A LEU 39 n 40 LEU 39 A LEU 40 n 41 LEU 40 A LYS 41 n 42 LYS 41 A GLY 42 n 43 GLY 42 A GLY 43 n 44 GLY 43 A SER 44 n 45 SER 44 A THR 45 n 46 THR 45 A LEU 46 n 47 LEU 46 A ASP 47 n 48 ASP 47 A GLU 48 n 49 GLU 48 A LEU 49 n 50 LEU 49 A PHE 50 n 51 PHE 50 A GLU 51 n 52 GLU 51 A GLU 52 n 53 GLU 52 A LEU 53 n 54 LEU 53 A ASP 54 n 55 ASP 54 A LYS 55 n 56 LYS 55 A ASN 56 n 57 ASN 56 A GLY 57 n 58 GLY 57 A ASP 58 n 59 ASP 58 A GLY 59 n 60 GLY 59 A GLU 60 n 61 GLU 60 A VAL 61 n 62 VAL 61 A SER 62 n 63 SER 62 A PHE 63 n 64 PHE 63 A GLU 64 n 65 GLU 64 A GLU 65 n 66 GLU 65 A PHE 66 n 67 PHE 66 A GLN 67 n 68 GLN 67 A VAL 68 n 69 VAL 68 A LEU 69 n 70 LEU 69 A VAL 70 n 71 VAL 70 A LYS 71 n 72 LYS 71 A LYS 72 n 73 LYS 72 A ILE 73 n 74 ILE 73 A SER 74 n 75 SER 74 A GLN 75 n 76 GLN 75 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N LEU 23 A N LEU 24 A O VAL 61 A O VAL 62 1 A MET 0 A MET 1 1 Y 2 A MET 0 A MET 1 1 Y 3 A MET 0 A MET 1 1 Y 4 A MET 0 A MET 1 1 Y 5 A MET 0 A MET 1 1 Y 6 A MET 0 A MET 1 1 Y 7 A MET 0 A MET 1 1 Y 8 A MET 0 A MET 1 1 Y 9 A MET 0 A MET 1 1 Y 10 A MET 0 A MET 1 1 Y 11 A MET 0 A MET 1 1 Y 12 A MET 0 A MET 1 1 Y 13 A MET 0 A MET 1 1 Y 14 A MET 0 A MET 1 1 Y 15 A MET 0 A MET 1 1 Y 16 A MET 0 A MET 1 1 Y 17 A MET 0 A MET 1 1 Y 18 A MET 0 A MET 1 1 Y 19 A MET 0 A MET 1 1 Y 20 A MET 0 A MET 1 1 Y 21 A MET 0 A MET 1 1 Y 22 A MET 0 A MET 1 1 Y 23 A MET 0 A MET 1 1 Y 24 A MET 0 A MET 1 1 Y 8 A A O OXT LYS GLN 1 75 1.74 16 A A O OXT LYS GLN 71 75 2.01 18 A A O OXT LYS GLN 71 75 1.78 19 A A O OXT LYS GLN 1 75 1.70 20 A A O OXT LYS GLN 71 75 2.00 24 A A O OXT LYS GLN 1 75 2.18 3 A PHE 50 0.091 SIDE CHAIN 4 A PHE 36 0.087 SIDE CHAIN 5 A PHE 50 0.079 SIDE CHAIN 6 A PHE 50 0.093 SIDE CHAIN 8 A PHE 50 0.112 SIDE CHAIN 9 A TYR 13 0.082 SIDE CHAIN 9 A PHE 50 0.097 SIDE CHAIN 10 A PHE 50 0.093 SIDE CHAIN 11 A PHE 50 0.099 SIDE CHAIN 12 A PHE 50 0.111 SIDE CHAIN 13 A TYR 13 0.074 SIDE CHAIN 15 A PHE 50 0.092 SIDE CHAIN 16 A TYR 13 0.096 SIDE CHAIN 16 A PHE 50 0.092 SIDE CHAIN 17 A PHE 36 0.105 SIDE CHAIN 17 A PHE 50 0.080 SIDE CHAIN 18 A PHE 50 0.092 SIDE CHAIN 19 A PHE 50 0.104 SIDE CHAIN 20 A TYR 13 0.115 SIDE CHAIN 20 A PHE 50 0.089 SIDE CHAIN 21 A PHE 50 0.105 SIDE CHAIN 22 A TYR 13 0.082 SIDE CHAIN 23 A TYR 13 0.066 SIDE CHAIN 23 A PHE 50 0.095 SIDE CHAIN 24 A PHE 50 0.086 SIDE CHAIN 3 A SER 74 64.06 -39.93 4 A GLU 17 78.57 -46.20 4 A SER 74 -178.18 -70.91 5 A SER 44 34.07 -93.12 5 A ASP 58 -139.81 -45.50 5 A SER 74 -159.61 -54.32 6 A GLU 17 60.74 116.24 6 A LYS 41 20.83 -88.18 6 A SER 44 52.25 -136.08 6 A SER 74 73.14 -62.31 7 A SER 74 -168.54 73.42 8 A LYS 16 -61.32 91.27 8 A GLU 17 77.53 -41.49 8 A LEU 40 51.20 -73.76 8 A LYS 55 -65.08 89.60 8 A ASP 58 -137.01 -42.51 9 A GLU 17 -154.62 -47.48 9 A SER 44 -26.54 -59.49 9 A ASN 56 28.92 48.81 10 A SER 44 55.10 -146.59 11 A LYS 41 -114.94 -151.63 11 A SER 44 52.22 -102.46 11 A ASN 56 39.85 38.28 11 A SER 74 45.27 -94.60 12 A LYS 16 -79.10 44.90 12 A GLU 17 -170.72 -51.17 12 A SER 44 35.51 -111.22 12 A ASN 56 37.91 41.19 13 A GLU 17 -139.94 -42.44 13 A ASP 54 -67.41 72.83 13 A LYS 55 -57.30 99.77 13 A ASN 56 95.75 5.32 13 A SER 74 -160.76 57.05 14 A GLU 17 -155.29 -45.76 14 A SER 74 -173.85 -47.82 15 A PHE 36 -145.34 56.91 15 A ASN 56 -154.28 32.12 16 A GLU 17 73.20 -37.21 16 A SER 44 57.00 -162.21 16 A ASP 54 -116.42 73.89 16 A ASN 56 -148.20 32.32 16 A ASP 58 -145.92 -18.79 16 A SER 74 -77.71 47.25 17 A GLU 17 54.85 109.71 17 A SER 44 55.78 -105.00 17 A SER 74 71.21 -63.76 18 A SER 44 -96.69 -89.57 18 A SER 74 -76.74 47.20 19 A GLU 17 -141.93 -43.49 19 A ASN 56 37.28 35.71 19 A SER 74 68.87 -51.43 20 A LYS 41 -107.62 -65.81 21 A SER 44 -171.09 -160.53 21 A ASN 56 -167.17 -47.85 22 A GLU 17 68.87 -60.43 22 A LYS 41 -105.77 -68.76 22 A ASN 56 129.70 -25.26 23 A ASN 56 -172.28 -37.65 24 A GLU 17 120.20 -56.65 24 A ASP 19 58.10 150.95 24 A LYS 41 26.36 -93.76 24 A SER 74 57.72 -84.71 Solution structure of (CD2+)1-calbindin D9K reveals details of the stepwise structural changes along the apo--> (CA2+)II1--> (CA2+)I,II2 binding pathway 1 Y N A PRO 3 A PRO 4 HELX_P A GLU 17 A GLU 18 1 1 15 A LYS 25 A LYS 26 HELX_P A GLU 35 A GLU 36 1 2 11 A LEU 46 A LEU 47 HELX_P A LEU 53 A LEU 54 1 3 8 A PHE 63 A PHE 64 HELX_P A ILE 73 A ILE 74 1 4 11 CALCIUM-BINDING PROTEIN EF-HAND, CALCIUM-BINDING PROTEIN S100G_BOVIN UNP 1 1 P02633 SAKKSPEELKGIFEKYAAKEGDPNQLSKEELKLLLQTEFPSLLKGPSTLDELFEELDKNGDGEVSFEEFQVLVKKISQ 4 78 1CDN 1 75 P02633 A 1 2 76 1 PRO engineered mutation GLY 43 1CDN A P02633 UNP 46 44 2 anti-parallel A GLN 22 A GLN 23 A LEU 23 A LEU 24 A VAL 61 A VAL 62 A SER 62 A SER 63 Unknown 14 Unknown 12 A ALA 14 A ALA 15 14 1_555 A ALA 15 A ALA 16 14 1_555 A LYS 16 A LYS 17 14 1_555 A GLU 17 A GLU 18 14 1_555 A GLY 18 A GLY 19 14 1_555 A ASP 19 A ASP 20 14 1_555 A PRO 20 A PRO 21 14 1_555 A ASN 21 A ASN 22 14 1_555 A GLN 22 A GLN 23 14 1_555 A LEU 23 A LEU 24 14 1_555 A SER 24 A SER 25 14 1_555 A LYS 25 A LYS 26 14 1_555 A GLU 26 A GLU 27 14 1_555 A GLU 27 A GLU 28 14 1_555 A ASP 54 A ASP 55 12 1_555 A LYS 55 A LYS 56 12 1_555 A ASN 56 A ASN 57 12 1_555 A GLY 57 A GLY 58 12 1_555 A ASP 58 A ASP 59 12 1_555 A GLY 59 A GLY 60 12 1_555 A GLU 60 A GLU 61 12 1_555 A VAL 61 A VAL 62 12 1_555 A SER 62 A SER 63 12 1_555 A PHE 63 A PHE 64 12 1_555 A GLU 64 A GLU 65 12 1_555 A GLU 65 A GLU 66 12 1_555 1 P 1